Microbiology
|
|---|
| Gray, Michael |
|
bacterial response to reactive chlorine stress, probiotics, gene regulation, bacterial physiology |
| Keeling, Kim |
|
Translation termination and nonsense-mediated mRNA decay |
| Lefkowitz, Elliot |
|
Microbial genomics, evolution, and bioinformatics |
| Michalek, Suzanne |
|
Francisella tularensis pathogenesis, mucosal immunology; vaccine delivery systems |
| Niederweis, Michael |
|
Novel proteins in the unique outer membrane of Mycobacterium tuberculosis; functions, structures, and role in virulence |
| Orihuela, Carlos J |
|
Host-pathogen interactions for development of invasive pneumococcal disease |
| Scoffield, Jessica |
|
Polymicrobial interactions in pulmonary and oral infections |
| Steyn, Andries |
|
Mechanism of Mycobacterium tuberculosis virulence |
| Turnbough, Charles |
|
Bacterial gene expression and regulation, structure and function of the Bacillus anthracis exosporium |
| Yother, Janet |
|
Streptococcus pneumoniae genetics and pathogenesis, capsular polysaccharides |
Pediatric Dentistry
|
|---|
| Wu, Hui |
|
Genetics and pathogenesis of oral infectious diseases |
Infectious Disease
|
|---|
| Wolschendorf, Frank |
|
Copper homeostasis of M. tuberculosis, drug discovery |
Pathology
|
|---|
| Moser, Steve |
|
Mycology, early diagnosis of fungal infections, molecular epidemiology, Streptococcus mutans |
| Nahm, Moon |
|
Vaccines, Streptococcus pneumoniae, bacterial pathogenesis, immunity |
| Waites, Ken |
|
Pathogenesis, chemotherapy, molecular epidemiology, and laboratory detection of Mycoplasma and Ureaplasma infections
|
Genetics
|
|---|
| Dybvig, Kevin |
|
Mycoplasmas, genetics, phenotypic switching, DNA rearrangements |
Biochemistry
|
|---|
| Bedwell, David |
|
Translation termination; treatment of genetic diseases |
| Higgins, N. Patrick |
|
Mobile DNA: structure, enzymology and regulation |
Southern Research
|
|---|
| Benitez, Jorge |
|
Global regulatory networks controlling bacterial behavior |
| Maddry, Joseph A. |
|
Mycobacterial disease and AIDS-related opportunistic infections |
| Parker, William B. |
|
Drug development based on purine and pyrimidine biochemistry |
| White, Lucile |
|
M. tuberculosis, N-acylamino acid, antitubercular agent, drug discovery/isolation, enzyme inhibitor, high throughput technology |